文献速递肝胆胰外科

微创远端胰腺切除术中逆行动脉优先入路治疗「肩部」胰腺癌

Retrograde artery first approach for "shoulder" pancreatic cancers in minimally invasive distal pancreatectomy.
PubMed 文献 · Surg Endosc · 2020-09-01

该研究提出「肩部」胰腺癌概念,即位于脾静脉汇入门静脉处的肿瘤,并回顾性分析11例连续病例,评估微创远端胰腺切除术中逆行动脉优先入路的安全性和有效性。主要结局为R0切除率,结果显示全部11例均实现R0切除,中位淋巴结清扫数为8枚。

要点

  • 「肩部」胰腺癌位于脾静脉汇入门静脉处,具有特定毗邻解剖。
  • 逆行动脉优先入路在11例中均实现R0切除,中位淋巴结8枚。
  • 该入路可能安全有效,但需更多证据支持。

核心结论

  • 「肩部」胰腺癌具有临床意义,逆行动脉优先入路是微创时代实现根治性切缘的潜在安全有效替代方案。

研究设计与样本

  • 回顾性分析2019年9月至2020年4月连续11例「肩部」胰腺癌患者,评估微创远端胰腺切除术中逆行动脉优先入路的安全性和有效性。
  • 主要结局为根治性(R0)切除率。

主要发现

  • 全部11例均实现R0切除。
  • 中位淋巴结清扫数为8枚(范围5-32)。
  • 脾静脉包绕比例为72.7%,脾动脉包绕比例为45.5%,肠系膜上静脉-门静脉壁侵犯比例为27.3%。
  • 病理最大肿瘤中位大小为35 mm(范围20-65)。
  • 中位手术时间260分钟(范围155-470),中位估计失血量200 ml(范围50-1000),1例需术中输血。

临床怎么用

  • 对于位于脾静脉汇入门静脉处的「肩部」胰腺癌,可考虑采用逆行动脉优先入路行微创远端胰腺切除术以实现R0切除。

局限性

  • 回顾性研究,样本量小(11例),结论需更多证据验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: "Shoulder" pancreatic cancer, defined as tumor located at the confluence where the splenic vein meets the portal vein, has specific adjacent anatomies. It's difficult to resect this type of tumor with adequate regional lymphadenectomy. METHODS: We described a new concept of "shoulder" pancreatic cancer, and retrospectively analyzed eleven consecutive cases from September 2019 to April 2020, to assess the safety and efficacy of the retrograde artery first approach in minimally invasive distal pancreatectomy. The primary outcome was set as radical (R0) resection rate. RESULTS: All of the 11 cases achieved R0 resection, with a median of 8 (range 5-32) lymph nodes harvested, given the ratio of embraced splenic vein in 72.7% of the cases, splenic artery embracement in 45.5%, and SMV-PV wall invasion in 27.3%. The maximum tumor size on pathology was 35 (range 20-65) mm. The median operative time was 260 (range 155-470) min, and the median estimated blood loss was 200 (range 50-1000) ml. One case needed intraoperative transfusion. One grade B postoperative pancreatic fistula occurred accompanied with abdominal infection, while the rest of cases recovered uneventful. The median postoperative length of stay was 9 (range 6-20) days. CONCLUSIONS: "Shoulder" pancreatic cancers are clinically significant. Retrograde artery first approach is a potentially safe and effective alternative to achieve a radical resection margin for shoulder pancreatic cancers in minimally invasive era. More evidences are needed in the future.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Tian F, Sun MQ, Lu J, et al. Retrograde artery first approach for "shoulder" pancreatic cancers in minimally invasive distal pancreatectomy. Surg Endosc. 2020. PMID: 32875408. doi:10.1007/s00464-020-07908-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。